FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter

PMA: P110016 · Supplement: S091 · Decision Jan 8, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P110016 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter
Trade Name
FlexAbility™ Ablation Catheter (Flex) and FlexAbility™ Ablation Catheter, Sensor Enabled™ (Flex SE)
PMA Number
P110016
Supplement Number
S091
Device Class
FDA Class 3
Product Code
OAD
Generic Name
catheter, percutaneous, cardiac ablation, for treatment of atrial flutter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
January 8, 2026
Date Received
December 9, 2025
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

process improvements at first tier suppliers

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OAD Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter